BigClassActions.com
Advertisement

Abiomed Inc, ABMD Securities Lawsuit

- by

Company: Abiomed Inc,
Ticker Symbol: ABMD
Class Period: Aug-5-11 to Oct-31-12
Date Filed: Nov-16-12
Lead Plaintiff Deadline: Jan-15-13
Court: District of Massachusetts
Allegations:
San Francisco, CA: A securities class action lawsuit has been filed on behalf of investors with large losses who purchased or otherwise acquired Abiomed Inc, Stock (NAS: ABMD) stock between Aug. 5, 2011, and Oct. 31, 2012,.

The lawsuit, filed on Nov. 16, 2012, in the U.S. District Court for the District of Massachusetts, alleges that Abiomed, Inc. made false or misleading statements to investors regarding possible Food and Drug Administration concerns about the marketing of its flagship product, the Impella 2.5 system.

On November 1, 2012, Abiomed disclosed that the Department of Justice is investigating the marketing of the Impella 2.5 system, which is used to improve blood flow in heart surgery patients and represents a strong revenue source for the company.

Following the disclosure of the DOJ probe, Abiomed stock fell more than 30 percent. The stock continues to trade more than 25 percent below its Oct. 31, 2012 high of nearly $20.00.

If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

Abiomed Inc, ABMD Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible Abiomed Inc, securities class action lawsuit. Please submit your complaint at right for a free evaluation.

Maybe it's your stockbroker
Last updated November 26 2012

Add Your Comment on This Issue

Please read our comment guidelines before posting.


Note: Your name will be published with your comment.


Your email will only be used if a response is needed.

Request Legal Help